Receptor Activity-Modifying Proteins (RAMPs): New Insights and Roles

被引:132
作者
Hay, Debbie L. [1 ,2 ]
Pioszak, Augen A. [3 ]
机构
[1] Univ Auckland, Sch Biol Sci, Auckland 1142, New Zealand
[2] Univ Auckland, Maurice Wilkins Ctr, Auckland 1142, New Zealand
[3] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA
来源
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 56 | 2016年 / 56卷
关键词
adrenomedullin; amylin; CGRP; calcium-sensing receptor; CRF; GPR30; heterodimer; GPCR; RAMP; VIP; GENE-RELATED PEPTIDE; CORTICOTROPIN-RELEASING-FACTOR; CLASS-B GPCR; CALCITONIN-RECEPTOR; COUPLED-RECEPTOR; EXTRACELLULAR DOMAIN; CGRP-RECEPTOR; ADRENOMEDULLIN RECEPTOR; CRYSTAL-STRUCTURE; DIFFERENTIALLY MODULATE;
D O I
10.1146/annurev-pharmtox-010715-103120
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
It is now recognized that G protein-coupled receptors (GPCRs), once considered largely independent functional units, have a far more diverse molecular architecture. Receptor activity-modifying proteins (RAMPs) provide an important example of proteins that interact with GPCRs to modify their function. RAMPsare able to act as pharmacological switches and chaperones, and they can regulate signaling and/or trafficking in a receptor-dependent manner. This review covers recent discoveries in the RAMP field and summarizes the knownGPCRpartners and functions of RAMPs. Wealso discuss the first peptide-bound structures of RAMP-GPCR complexes, which give insight into the molecular mechanisms that enable RAMPs to alter the pharmacology and signaling of GPCRs.
引用
收藏
页码:469 / 487
页数:19
相关论文
共 102 条
[1]  
[Anonymous], J PHARM ALLIED HLTH, DOI [10.3923/jpahs.2011.1.15, DOI 10.3923/JPAHS.2011.1.15]
[2]   Structural insights into RAMP modification of secretin family G protein-coupled receptors: implications for drug development [J].
Archbold, Julia K. ;
Flanagan, Jack U. ;
Watkins, Harriet A. ;
Gingell, Joseph J. ;
Hay, Debbie L. .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2011, 32 (10) :591-600
[3]   Agonist-dependent consequences of proline to alanine substitution in the transmembrane helices of the calcitonin receptor [J].
Bailey, R. J. ;
Hay, D. L. .
BRITISH JOURNAL OF PHARMACOLOGY, 2007, 151 (05) :678-687
[4]   Pharmacology of the human CGRP1 receptor in Cos 7 cells [J].
Bailey, Richard J. ;
Hay, Debbie L. .
PEPTIDES, 2006, 27 (06) :1367-1375
[5]   Loss of receptor activity-modifying protein 3 exacerbates cardiac hypertrophy and transition to heart failure in a sex-dependent manner [J].
Barrick, Cordelia J. ;
Lenhart, Patricia M. ;
Dackor, Ryan T. ;
Nagle, Elizabeth ;
Caron, Kathleen M. .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2012, 52 (01) :165-174
[6]   Calcitonin and calcitonin receptor-like receptors: common themes with family B GPCRs? [J].
Barwell, James ;
Gingell, Joseph J. ;
Watkins, Harriet A. ;
Archbold, Julia K. ;
Poyner, David R. ;
Hay, Debbie L. .
BRITISH JOURNAL OF PHARMACOLOGY, 2012, 166 (01) :51-65
[7]   Extracellular loops 1 and 3 and their associated transmembrane regions of the calcitonin receptor-like receptor are needed for CGRP receptor function [J].
Barwell, James ;
Conner, Alex ;
Poyner, David R. .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2011, 1813 (10) :1906-1916
[8]  
Benitez-Paez Alfonso, 2006, In Silico Biology, V6, P467
[9]   Receptor activity-modifying protein (RAMP) isoform-specific regulation of adrenomedullin receptor trafficking by NHERF-1 [J].
Bomberger, JM ;
Spielman, WS ;
Hall, CS ;
Weinman, EJ ;
Parameswaran, N .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (25) :23926-23935
[10]   Novel function for receptor activity-modifying proteins (RAMPs) in post-endocytic receptor trafficking [J].
Bomberger, JM ;
Parameswaran, N ;
Hall, CS ;
Aiyar, N ;
Spielman, WS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (10) :9297-9307